{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:21:07Z","timestamp":1759332067155},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,11,20]],"date-time":"2014-11-20T00:00:00Z","timestamp":1416441600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s00432-014-1875-0","type":"journal-article","created":{"date-parts":[[2014,11,21]],"date-time":"2014-11-21T15:34:49Z","timestamp":1416584089000},"page":"1073-1081","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Current status of chemotherapy use and clinical outcome in octogenarians with advanced non-small cell lung cancer"],"prefix":"10.1007","volume":"141","author":[{"given":"Sung Hoon","family":"Sim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Se Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhumsuk","family":"Keam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Se-Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Wan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae Seog","family":"Heo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Seok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,20]]},"reference":[{"issue":"2","key":"1875_CR1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/JTO.0b013e3180311792","volume":"2","author":"O Altundag","year":"2007","unstructured":"Altundag O, Stewart DJ, Fossella FV, Ayers GD, Wei W, Zhou X, Zinner RG (2007) Many patients 80\u00a0years and older with advanced non-small cell lung cancer (NSCLC) can tolerate chemotherapy. J Thorac Oncol 2(2):141\u2013146","journal-title":"J Thorac Oncol"},{"key":"1875_CR2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1200\/JCO.2007.12.8322","volume":"26","author":"TR Asmis","year":"2008","unstructured":"Asmis TR et al (2008) Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials. J Clin Oncol 26:54\u201359. doi: 10.1200\/JCO.2007.12.8322","journal-title":"J Clin Oncol"},{"key":"1875_CR3","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1634\/theoncologist.5-3-224","volume":"5","author":"L Balducci","year":"2000","unstructured":"Balducci L, Extermann M (2000) Management of cancer in the older person: a practical approach. Oncologist 5:224\u2013237","journal-title":"Oncologist"},{"key":"1875_CR4","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/JTO.0b013e3181d89b48","volume":"5","author":"EM Blanchard","year":"2010","unstructured":"Blanchard EM, Arnaoutakis K, Hesketh PJ (2010) Lung cancer in octogenarians. J Thorac Oncol 5:909\u2013916","journal-title":"J Thorac Oncol"},{"key":"1875_CR5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.lungcan.2010.05.001","volume":"69","author":"P Blinman","year":"2010","unstructured":"Blinman P, Alam M, Duric V, McLachlan SA, Stockler MR (2010) Patients\u2019 preferences for chemotherapy in non-small-cell lung cancer: a systematic review. Lung Cancer 69:141\u2013147. doi: 10.1016\/j.lungcan.2010.05.001","journal-title":"Lung Cancer"},{"key":"1875_CR6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373\u2013383","journal-title":"J Chronic Dis"},{"key":"1875_CR7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0169-5002(03)00031-X","volume":"40","author":"YM Chen","year":"2003","unstructured":"Chen YM, Perng RP, Chen MC, Tsai CM, Ming-Liu J, Whang-Peng J (2003) A phase II trial of vinorelbine plus gemcitabine in previously untreated inoperable (stage IIIb\/IV) non-small-cell lung cancer patients aged 80 or older. Lung Cancer 40:221\u2013226","journal-title":"Lung Cancer"},{"key":"1875_CR8","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/JTO.0b013e3181c09b28","volume":"5","author":"KY Chen","year":"2010","unstructured":"Chen KY, Chen JH, Shih JY, Yang CH, Yu CJ, Yang PC (2010) Octogenarians with advanced non-small cell lung cancer: treatment modalities, survival, and prognostic factors. J Thorac Oncol 5:82\u201389. doi: 10.1097\/JTO.0b013e3181c09b28","journal-title":"J Thorac Oncol"},{"key":"1875_CR9","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1200\/JCO.2009.23.8485","volume":"28","author":"EA Chrischilles","year":"2010","unstructured":"Chrischilles EA et al (2010) Adverse events among the elderly receiving chemotherapy for advanced non-small-cell lung cancer. J Clin Oncol 28:620\u2013627. doi: 10.1200\/JCO.2009.23.8485","journal-title":"J Clin Oncol"},{"key":"1875_CR10","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1200\/JCO.2009.25.4052","volume":"28","author":"AJ Davidoff","year":"2010","unstructured":"Davidoff AJ, Tang M, Seal B, Edelman MJ (2010) Chemotherapy and survival benefit in elderly patients with advanced non-small-cell lung cancer. J Clin Oncol 28:2191\u20132197. doi: 10.1200\/JCO.2009.25.4052","journal-title":"J Clin Oncol"},{"key":"1875_CR11","doi-asserted-by":"crossref","unstructured":"Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer. The Elderly Lung Cancer Vinorelbine Italian Study Group (1999) Journal of the National Cancer Institute 91:66\u201372","DOI":"10.1093\/jnci\/91.1.66"},{"key":"1875_CR12","doi-asserted-by":"crossref","first-page":"645","DOI":"10.6004\/jnccn.2013.0084","volume":"11","author":"DS Ettinger","year":"2013","unstructured":"Ettinger DS et al (2013) Non-small cell lung cancer, version 2.2013. J Natl Compr Cancer Netw 11:645\u2013653 quiz 653","journal-title":"J Natl Compr Cancer Netw"},{"key":"1875_CR13","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1200\/JCO.2000.18.13.2529","volume":"18","author":"G Frasci","year":"2000","unstructured":"Frasci G et al (2000) Gemcitabine plus vinorelbine versus vinorelbine alone in elderly patients with advanced non-small-cell lung cancer. J Clin Oncol 18:2529\u20132536","journal-title":"J Clin Oncol"},{"key":"1875_CR14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12094-012-0782-6","volume":"14","author":"R Girones","year":"2012","unstructured":"Girones R, Torregrosa D, Gomez-Codina J, Maestu I, Tenias JM, Rosell R (2012) Lung cancer chemotherapy decisions in older patients: the role of patient preference and interactions with physicians. Clin Transl Oncol 14:183\u2013189. doi: 10.1007\/s12094-012-0782-6","journal-title":"Clin Transl Oncol"},{"key":"1875_CR15","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/jnci\/95.5.362","volume":"95","author":"C Gridelli","year":"2003","unstructured":"Gridelli C et al (2003) Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial. J Natl Cancer Inst 95:362\u2013372","journal-title":"J Natl Cancer Inst"},{"key":"1875_CR16","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1200\/JCO.2005.01.388","volume":"23","author":"SW Han","year":"2005","unstructured":"Han SW et al (2005) Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib. J Clin Oncol 23:2493\u20132501. doi: 10.1200\/JCO.2005.01.388","journal-title":"J Clin Oncol"},{"key":"1875_CR17","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/JTO.0b013e318060097e","volume":"2","author":"PJ Hesketh","year":"2007","unstructured":"Hesketh PJ et al (2007) Chemotherapy in patients\u00a0>\u00a0or\u00a0=\u00a080 with advanced non-small cell lung cancer: combined results from SWOG 0027 and LUN 6. J Thorac Oncol 2:494\u2013498. doi: 10.1097\/JTO.0b013e318060097e","journal-title":"J Thorac Oncol"},{"key":"1875_CR18","unstructured":"Howlader N NA KM, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (2014) SEER Cancer Statistics Review 1975\u20132011 National Cancer Institute. Bethesda, MD, http:\/\/seer.cancer.gov\/csr\/1975_2011\/ , based on November 2013 SEER data submission, posted to the SEER web site"},{"key":"1875_CR19","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1056\/NEJM199912303412706","volume":"341","author":"LF Hutchins","year":"1999","unstructured":"Hutchins LF, Unger JM, Crowley JJ, Coltman CA Jr, Albain KS (1999) Underrepresentation of patients 65\u00a0years of age or older in cancer-treatment trials. New Engl J Med 341:2061\u20132067. doi: 10.1056\/NEJM199912303412706","journal-title":"New Engl J Med"},{"key":"1875_CR20","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1200\/JCO.2008.18.7658","volume":"27","author":"A Inoue","year":"2009","unstructured":"Inoue A et al (2009) First-line gefitinib for patients with advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutations without indication for chemotherapy. J Clin Oncol 27:1394\u20131400. doi: 10.1200\/JCO.2008.18.7658","journal-title":"J Clin Oncol"},{"key":"1875_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4143\/crt.2013.45.1.1","volume":"45","author":"KW Jung","year":"2013","unstructured":"Jung KW, Won YJ, Kong HJ, Oh CM, Seo HG, Lee JS (2013) Cancer statistics in Korea: incidence, mortality, survival and prevalence in 2010. Cancer Res Treat 45:1\u201314. doi: 10.4143\/crt.2013.45.1.1","journal-title":"Cancer Res Treat"},{"key":"1875_CR22","doi-asserted-by":"crossref","first-page":"3657","DOI":"10.1200\/JCO.2006.06.1044","volume":"24","author":"S Kudoh","year":"2006","unstructured":"Kudoh S et al (2006) Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904). J Clin Oncol 24:3657\u20133663. doi: 10.1200\/JCO.2006.06.1044","journal-title":"J Clin Oncol"},{"key":"1875_CR23","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1097\/JTO.0b013e318260de8b","volume":"7","author":"M Maemondo","year":"2012","unstructured":"Maemondo M et al (2012) First-line gefitinib in patients aged 75 or older with advanced non-small cell lung cancer harboring epidermal growth factor receptor mutations: NEJ 003 study. J Thorac Oncol 7:1417\u20131422. doi: 10.1097\/JTO.0b013e318260de8b","journal-title":"J Thorac Oncol"},{"key":"1875_CR24","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/JTO.0b013e318158d4a2","volume":"2","author":"GR Oxnard","year":"2007","unstructured":"Oxnard GR, Fidias P, Muzikansky A, Sequist LV (2007) Non-small cell lung cancer in octogenarians: treatment practices and preferences. J Thorac Oncol 2:1029\u20131035. doi: 10.1097\/JTO.0b013e318158d4a2","journal-title":"J Thorac Oncol"},{"key":"1875_CR25","doi-asserted-by":"crossref","unstructured":"Pallis AG et al. (2010) EORTC Elderly Task Force and Lung Cancer Group and International Society for Geriatric Oncology (SIOG) experts\u2019 opinion for the treatment of non-small-cell lung cancer in an elderly population Annals of oncology : official journal of the European Society for Medical Oncology\/ESMO 21:692-706 doi: 10.1093\/annonc\/mdp360","DOI":"10.1093\/annonc\/mdp360"},{"key":"1875_CR26","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/annonc\/mdu022","volume":"25","author":"AG Pallis","year":"2014","unstructured":"Pallis AG et al (2014) Management of elderly patients with NSCLC; updated expert\u2019s opinion paper: EORTC Elderly Task Force, Lung Cancer Group and International Society for Geriatric Oncology. Ann Oncol 25:1270\u20131283. doi: 10.1093\/annonc\/mdu022","journal-title":"Ann Oncol"},{"key":"1875_CR27","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.cllc.2012.10.007","volume":"14","author":"JH Park","year":"2013","unstructured":"Park JH et al (2013) Tumor burden is predictive of survival in patients with non-small-cell lung cancer and with activating epidermal growth factor receptor mutations who receive gefitinib. Clin Lung Cancer 14:383\u2013389. doi: 10.1016\/j.cllc.2012.10.007","journal-title":"Clin Lung Cancer"},{"key":"1875_CR28","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.lungcan.2011.06.006","volume":"74","author":"E Quoix","year":"2011","unstructured":"Quoix E, Westeel V, Zalcman G, Milleron B (2011a) Chemotherapy in elderly patients with advanced non-small cell lung cancer. Lung Cancer 74:364\u2013368. doi: 10.1016\/j.lungcan.2011.06.006","journal-title":"Lung Cancer"},{"key":"1875_CR29","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0140-6736(11)60780-0","volume":"378","author":"E Quoix","year":"2011","unstructured":"Quoix E et al (2011b) Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial. Lancet 378:1079\u20131088. doi: 10.1016\/S0140-6736(11)60780-0","journal-title":"Lancet"},{"key":"1875_CR30","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ejca.2008.08.020","volume":"45","author":"L Repetto","year":"2009","unstructured":"Repetto L, Piselli P, Raffaele M, Locatelli C (2009) Gioger communicating cancer diagnosis and prognosis: when the target is the elderly patient-a GIOGer study. Eur J Cancer 45:374\u2013383. doi: 10.1016\/j.ejca.2008.08.020","journal-title":"Eur J Cancer"},{"key":"1875_CR31","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/JTO.0b013e31827e2145","volume":"8","author":"AG Sacher","year":"2013","unstructured":"Sacher AG, Le LW, Leighl NB, Coate LE (2013) Elderly patients with advanced NSCLC in phase III clinical trials: are the elderly excluded from practice-changing trials in advanced NSCLC? J Thorac Oncol 8:366\u2013368. doi: 10.1097\/JTO.0b013e31827e2145","journal-title":"J Thorac Oncol"},{"key":"1875_CR32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1145\/3386158","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA 63:11\u201330. doi: 10.3322\/caac.21166","journal-title":"CA"},{"key":"1875_CR33","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1200\/JCO.2006.06.8015","volume":"25","author":"J Subramanian","year":"2007","unstructured":"Subramanian J, Govindan R (2007) Lung cancer in never smokers: a review. J Clin Oncol 25:561\u2013570. doi: 10.1200\/JCO.2006.06.8015","journal-title":"J Clin Oncol"},{"key":"1875_CR34","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","volume":"92","author":"P Therasse","year":"2000","unstructured":"Therasse P et al (2000) New guidelines to evaluate the response to treatment in solid tumors European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205\u2013216","journal-title":"J Natl Cancer Inst"},{"key":"1875_CR35","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1200\/JCO.2011.39.5269","volume":"30","author":"S Wang","year":"2012","unstructured":"Wang S, Wong ML, Hamilton N, Davoren JB, Jahan TM, Walter LC (2012) Impact of age and comorbidity on non-small-cell lung cancer treatment in older veterans. J Clin Oncol 30:1447\u20131455. doi: 10.1200\/JCO.2011.39.5269","journal-title":"J Clin Oncol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-014-1875-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-014-1875-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-014-1875-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T03:29:51Z","timestamp":1598498991000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-014-1875-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,20]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["1875"],"URL":"https:\/\/doi.org\/10.1007\/s00432-014-1875-0","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,20]]}}}